ImmunoGen Inc (NASDAQ:IMGN)
| 4.71 Delayed Data As of 3:59pm ET |  +0.05 / +1.07%Today’s Change | 3.10 Today|||52-Week Range 6.63 | -5.04% Year-to-Date |
Latest IMGN News | Press Releases
| Cigna (CI) to Post Q4 Earnings: Here's What You Should Know Jan 31 / Zacks.com - Paid Partner Content | HCA Healthcare (HCA) to Post Q4 Earnings: What's in the Cards? Jan 24 / Zacks.com - Paid Partner Content |
| Can Humana's (HUM) Q4 Earnings Beat on Healthcare Services? Jan 30 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 4.66 |
| Today’s open | 4.58 |
| Day’s range | 4.56 - 4.75 |
| Volume | 70,258 |
| Average volume (3 months) | 3,573,255 |
| Market cap | $1.0B |
Data as of 3:59pm ET, 02/06/2023
Growth & Valuation
| Earnings growth (last year) | -168.28% |
| Earnings growth (this year) | -38.86% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -47.20% |
| P/E ratio | NM |
| Price/Sales | 21.90 |
| Price/Book | 3.16 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RGNXRegenxbio Inc | -0.48 | -2.02% |
| CDMOAvid Bioservices Inc | +0.92 | +5.68% |
| QUREUniqure NV | -0.04 | -0.16% |
| COGTCogent Biosciences I... | -0.26 | -1.71% |
Data as of 3:59pm ET, 02/06/2023
Financials
| Next reporting date | February 10, 2023 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $69.9M |
| Annual profit (last year) | -$139.3M |
| Net profit margin | -199.41% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
